All Posts: neuroscience
-
Brain Wars of Star Wars: Fact or Fiction?
WASHINGTON – “Science fiction is often the driver of science fact.” So says Georgetown neuroethicist James Giordano, PhD, MPhil, when asked about one of the most popular science fiction movies, “Star Wars” and the seventh installment: “Star Wars: The Force Awakens.”
Category: News Release
-
Researchers Report First Therapy Appearing to Reverse Decline in Parkinson’s
OCTOBER 17, 2015 – An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC). The drug, nilotinib (known as Tasigna® by Novartis) also led to statistically significant and encouraging changes in toxic […]
Category: GUMC Stories
-
Cancer Drug Improved Cognition and Motor Skills in Small Parkinson’s Clinical Trial
CHICAGO (Oct. 17, 2015) — An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small phase I clinical trial, report researchers at Georgetown University Medical Center (GUMC) in Washington. In addition, the drug, nilotinib (Tasigna® by Novartis), led to statistically significant […]
Category: News Release
-
Small Grants Supply the Research “Lifeblood” of Early Career Scientists
Three GUMC researchers describe the immeasurable impact of small grants from philanthropic organizations, foundations and the government on their work.
Category: GUMC Stories
-
Neuroscience Student Elected to the Board of the American Tinnitus Association
Neuroscience PhD student Ted Turesky hadn’t even heard of tinnitus when he first came to Georgetown. In July, he was elected to the board of the American Tinnitus Association.
Category: GUMC Stories
-
Researcher Debunks Alzheimer's Prevailing Development Theory
(October 31, 2014) – New research that dramatically alters the prevailing theory of how Alzheimer’s disease develops has been published online today by Georgetown researchers in the journal Molecular Neurodegeneration. The research also helps explains why some people with plaque buildup in their brains don’t develop dementia, and shows the potential of a cancer drug […]
Category: GUMC Stories
-
Tau, Not Amyloid-beta, Triggers Neuronal Death Process in Alzheimer’s
WASHINGTON (Oct. 31, 2014) — New research points to malfunctioning tau, not amyloid-beta (Abeta) plaque, as the seminal event that spurs neuron death in disorders such as Alzheimer’s disease. The finding, which dramatically alters the prevailing theory of Alzheimer’s development, also explains why some people with plaque build-up in their brains don’t have dementia. The […]
Category: News Release
-
Seeding the Work of GUMC's Young Neuroscience Investigators
(May 30, 2013) — Talk of continued successes punctuated the conversations of more than 150 guests at Georgetown University Medical Center’s (GUMC) third annual “Music for the Mind,” a spring fundrais
Category: GUMC Stories
-
Cancer Drug Prevents Build-up of Toxic Brain Protein
WASHINGTON (May 10, 2013) — Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson’s disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published […]
Category: News Release
-
Removing Protein “Garbage” in Nerve Cells May Help Control Two Neurodegenerative Diseases
Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.
Category: News Release